Innovia, the Cumbria-based manufacturer of high-tech films, has announced the sale of its Cellophane business to Futamura Chemicals, a Japanese packaging firm.
Financial details of the deal were not disclosed.
Innovia said the sale of Cellophane, which generated revenues in 2015 of €118m (£95m), would enable it concentrate on producing polymer banknotes and its biaxially-oriented polypropylene (BOPP) films business.
The company declined to reveal the business’ profit numbers.
Speaking about the sale, Mark Robertshaw, Innovia’s chief executive, said Futamura would be a good home for the business, while the deal was an important strategic step for his group.
“Futamura is an excellent long-term owner for Cellophane, with its core business focussed on cellulose and plastic films.
“In line with our strategy, we will continue to focus on building our polymer films and banknote business where we see significant growth potential.
“In particular, the benefits of our polymer technology for banknotes have proven to reduce counterfeiting levels significantly and to reduce substantially the lifetime costs to central banks which we expect will continue to drive long term demand for polymer banknotes across the globe.”
President of Futamura Chemical, Yasuo Nagae, said of the deal: “The acquisition of the Innovia’s Cellophane business will enhance our product range and presence across the globe.
“It supports our ambition to serve our key customers through local manufacturing facilities offering the highest standards of delivery by experienced personnel. We look forward to welcoming Innovia’s Cello employees into our family.”
Cellophane, which has been based in Innovia’s Wigton facility since the early 1930s, currently employs a workforce of 471, according to a spokeswoman. The plant will remain onsite, as will its staff.
Innovia is providing the polymer substrate for the new UK £5 banknote, which comes into circulation in September, and the new £10 banknote, which is due to be issued in September 2017.
Source: Plastics and Rubber Weekly
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.
